40 Hz Visual Stimulation During Sleep Evokes Neuronal Gamma Activity in NREM and REM Stages DOI Creative Commons
Laura Hainke, James Dowsett, Manuel Spitschan

et al.

SLEEP, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 18, 2024

Abstract Study Objectives Visual stimulation (VS) at 40 Hz is being tested as a non-invasive approach against dementias such Alzheimer’s disease. Applying it during sleep could increase the convenience, duration, and efficacy of stimulation. Here, we feasibility VS in proof-of-concept study. Methods Thirty healthy participants underwent one control experimental night polysomnography laboratory. was delivered wakefulness (W), NREM stages 2 3, REM sleep. Results As expected, EEG spectral power increased all four condition, compared to control. It highest W similar across 2, REM, with large medium effect sizes, respectively. Steady-state visually evoked potential (SSVEP) analyses time domain confirmed specificity effect. Secondary revealed that intervention did not impair objective subjective quality beyond first-night Conclusions effectively neuronal gamma activity frequency without degrading quality, supporting this approach. These findings lay groundwork for optimizing gamma-band sensory tool causally study cognitive functions scalable, dementias.

Language: Английский

Mechanisms of phototherapy of Alzheimer’s disease during sleep and wakefulness: the role of the meningeal lymphatics DOI Creative Commons

Semyachkina-Glushkovskaya Oxana,

Shirokov Alexander,

Blokhina Inna

et al.

Frontiers of Optoelectronics, Journal Year: 2023, Volume and Issue: 16(1)

Published: Sept. 18, 2023

With the increase in aging population, global number of people with Alzheimer's disease (AD) progressively increased worldwide. The situation is aggravated by fact that there no effective pharmacological therapy AD. Photobiomodulation (PBM) non-pharmacological approach has shown very promising results AD pilot clinical and animal studies. However, mechanisms therapeutic effects PBM for are poorly understood. In this study on mice, we demonstrate photodynamic 5-aminolevulenic acid laser 635 nm cause reduction network meningeal lymphatic vessels (MLVs) leading to suppression removal beta-amyloid (Aβ) from right lateral ventricle hippocampus. Using original protocol under electroencephalographic monitoring wakefulness sleep stages non-anesthetized discover 7-day course during deep vs. provides better restoration clearance Aβ ventricular system brain Our shed light mechanism show stimulating drainage promotes transport via pathway. lymphatics sleeping open a new niche restorative functions as well it an important informative platform development innovative smart technologies

Language: Английский

Citations

17

Phototherapy for age-related brain diseases: Challenges, successes and future DOI Creative Commons
Ling Ding,

Ziqi Gu,

Haishu Chen

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 94, P. 102183 - 102183

Published: Jan. 11, 2024

Brain diseases present a significant obstacle to both global health and economic progress, owing their elusive pathogenesis the limited effectiveness of pharmaceutical interventions. Phototherapy has emerged as promising non-invasive therapeutic modality for addressing age-related brain disorders, including stroke, Alzheimer's disease (AD), Parkinson's (PD), among others. This review examines recent progressions in phototherapeutic Firstly, article elucidates various wavelengths visible light that possess capability penetrate skin skull, well pathways stimulation, encompassing eyes, skin, veins, skull. Secondly, it deliberates on molecular mechanisms photosensitive proteins, within context disorders other modulation. Lastly, practical application phototherapy diverse clinical neurological is indicated. Additionally, this presents novel approaches combine pharmacological Moreover, outlines limitations phototherapeutics proposes innovative strategies improve treatment cerebral disorders.

Language: Английский

Citations

6

Quantification and stimulation of human glymphatic dynamics:New features of Alzheimer’s disease and effects of brain photobiomodulation DOI Creative Commons

Fiza Saeed,

Kathy L. Siepker,

Soeun Jang

et al.

Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown

Published: March 5, 2025

A non-invasive device to measure the dynamics of cerebrospinal fluid (CSF) is highly desirable because CSF facilitates cleaning neurotoxic wastes in brain. better understanding helps promote healthy aging older adults and treat patients with neurological diseases. This study employed a multi-color optical method quantify prefrontal two groups: (1) (n = 16) without 27) Alzheimer's disease (2) young 26) before after light stimulation. The results revealed that coupling strengths between cerebral blood volume (CBV) were age-dependent significantly higher AD than controls. Prefrontal stimulation enhanced CBV-CSF coupling, suggesting improved drainage. underscores strategy as unique tool for monitoring interaction CBV CSF, well metabolic functions human brain, while demonstrating therapeutic potential brain treating neurodegenerative diseases involving drainage dysfunction.

Language: Английский

Citations

0

Technology of the photobiostimulation of the brain’s drainage system during sleep for improvement of learning and memory in male mice DOI Creative Commons
Oxana Semyachkina‐Glushkovskaya, Ivan V. Fedosov, Alexey Zaikin

et al.

Biomedical Optics Express, Journal Year: 2023, Volume and Issue: 15(1), P. 44 - 44

Published: Nov. 24, 2023

In this study on healthy male mice using confocal imaging of dye spreading in the brain and its further accumulation peripheral lymphatics, we demonstrate stronger effects photobiomodulation (PBM) brain's drainage system sleeping vs. awake animals. Using Pavlovian instrumental transfer probe 2-objects-location test, found that 10-day course PBM during sleep wakefulness promotes improved learning spatial memory mice. For first time, present technology for under electroencephalographic (EEG) control incorporates modern state art facilities optoelectronics biopotential detection can be built relatively cheap commercially available components. These findings open a new niche development smart technologies phototherapy diseases sleep.

Language: Английский

Citations

10

Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease DOI Creative Commons
Nikita Navolokin,

Viktoria Adushkina,

Daria Zlatogorskaya

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(6), P. 788 - 788

Published: June 16, 2024

The COVID-19 pandemic, caused by infection with the SARS-CoV-2 virus, is associated cognitive impairment and Alzheimer’s disease (AD) progression. Once it enters brain, virus stimulates accumulation of amyloids in brain that are highly toxic to neural cells. These may trigger neurological symptoms COVID-19. meningeal lymphatic vessels (MLVs) play an important role removal toxins mediate viral drainage from brain. MLVs considered a promising target prevent COVID-19-exacerbated dementia. However, there limited methods for augmentation MLV function. This review highlights new discoveries field COVID-19-mediated amyloid development strategies stimulate clearance through other pathways. based on innovative treating dysfunction induced infection, including use photobiomodulation, plasmalogens, medicinal herbs, which offer hope addressing challenges posed virus.

Language: Английский

Citations

3

Transcranial Photosensitizer-Free Laser Treatment of Glioblastoma in Rat Brain DOI Open Access
Oxana Semyachkina‐Glushkovskaya, Sergei G. Sokolovski, Ivan V. Fedosov

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(18), P. 13696 - 13696

Published: Sept. 5, 2023

Over sixty years, laser technologies have undergone a technological revolution and become one of the main tools in biomedicine, particularly neuroscience, neurodegenerative diseases brain tumors. Glioblastoma is most lethal form cancer, with very limited treatment options poor prognosis. In this study on rats, we demonstrate that glioblastoma (GBM) growth can be suppressed by photosensitizer-free (PS-free-LT) using quantum-dot-based 1267 nm diode. This wavelength, highly absorbed oxygen, capable turning triplet oxygen to singlet form. Applying irradiation for 4 week course total dose 12.7 kJ/cm

Language: Английский

Citations

8

Photo-sleep therapy of Alzheimer’s disease DOI
Andrey Terskov, Arina Evsukova, Inna Blokhina

et al.

The European Physical Journal Special Topics, Journal Year: 2024, Volume and Issue: 233(3), P. 685 - 690

Published: April 2, 2024

Language: Английский

Citations

2

New insights into phototherapy of glioblastoma: the meningeal lymphatics and sleep DOI
Alexander Shirokov,

Egor Ilukov,

Inna Blokhina

et al.

The European Physical Journal Special Topics, Journal Year: 2024, Volume and Issue: 233(3), P. 691 - 697

Published: Jan. 25, 2024

Language: Английский

Citations

1

Photobiomodulation Literature Watch July 2023 DOI
James D. Carroll

Photobiomodulation Photomedicine and Laser Surgery, Journal Year: 2024, Volume and Issue: 42(4), P. 324 - 326

Published: March 27, 2024

Language: Английский

Citations

0

Editorial on the special issue on neuro-sleep as a complex system DOI Creative Commons
Oxana Semyachkina‐Glushkovskaya, А. Н. Павлов,

Maria Farsari

et al.

The European Physical Journal Special Topics, Journal Year: 2024, Volume and Issue: 233(3), P. 457 - 462

Published: April 23, 2024

Language: Английский

Citations

0